Academic Journals Database
Disseminating quality controlled scientific knowledge

Search Articles for "Bevacizumab"

ADD TO MY LIST
 
Intracameral bevacizumab administered for non-small cell lung cancer metastasis to iris

Author(s): Jonathan C. Schell | Steven B. Koenig | Kenneth Bastin | William J. Wirostko
Targeted therapies in the management of renal cell carcinoma: role of bevacizumab

Author(s): Bernard Escudier | Jan Cosaert | Sangeeta Jethwa
Coronary Vasospasm Secondary to 5-Fluorouracil and Its Management: Case Report

Author(s): Mustafa Yildirim | Cem Parlak | Cem Sezer | Ramazan Eryilmaz | Cetin Kaya | Mustafa Yildiz
Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer

Author(s): Zacharenia Saridaki, Vassilis Georgoulias, John Souglakos
Update and developments in the treatment of glioblastoma multiforme – focus on bevacizumab

Author(s): Naveed Wagle | Leia Nghiemphu | Albert Lai | et al
Anti-angiogenesis therapies: their potential in cancer management

Author(s): Andrew Eichholz | Shairoz Merchant | Andrew M Gaya
Role of bevacizumab therapy in the management of glioblastoma

Author(s): Scott J Peak | Victor A Levin
Everolimus – a new approach in the treatment of renal cell carcinoma

Author(s): G Anandappa | AE Hollingdale | TG Eisen
Targeted therapy in melanoma

Author(s): Hussein Tawbi | Neelima Nimmagadda
Bevacizumab for Macular Serous Neuroretinal Detachment in Tilted Disk Syndrome

Author(s): Paolo Milani | Alfredo Pece | Luisa Pierro | Patrizio Seidenari | Paolo Radice | Antonio Scialdone
Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib

Author(s): Christina Wich, Abbas Agaimy, Deike Strobel, Thaddäus Till Wissniowski, Arndt Hartmann, Matthias Ocker
Targeted medical therapy of biliary tract cancer: Recent advances and future perspectives

Author(s): Michael Höpfner, Detlef Schuppan, Hans Scherübl
Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture

Author(s): J. Fernando Arevalo | Juan G. Sanchez | Andres F. Lasave | Lihteh Wu | Mauricio Maia | Sergio Bonafonte | Miguel Brito | Arturo A. Alezzandrini | Natalia Restrepo | Maria H. Berrocal | Mario Saravia | Michel Eid Farah | Jans Fromow-Guerra | Virgilio Morales-Canton
Choroidal neovascularization associated with coloboma of the choroid: A series of three cases

Author(s): Bhende Muna | Suganeswari G | Gopal Lingam | Bhende Pramod | Gopal Lekha | Rao Chetan
Brain microischemic phenomena in a woman receiving bevacizumab treatment: a case report

Author(s): Quattrocchi Carlo | Alexandre Andrea | Tonini Giuseppe | Errante Yuri | Grasso Rosario | Zobel Bruno
Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion

Author(s): Juan Carlos Mesa Gutiérrez | Luis Arias Barquet | Josep Maria Caminal Mitjana | Sergi Prades Almolda | Nùria Planas Domènech | et al
Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer

Author(s): Thérèse H Franco | Ahmed Khan | Vishal Joshi | Beje Thomas
Posterior capsule opacification and neovascularization treated with intravitreal bevacizumab and Nd:YAG capsulotomy

Author(s): Grimelda Yuriana Sánchez-Castro | Alejandra Hitos-Fájer | Erick Mendoza-Schuster | Raul Velez-Montoya | Cecilio Francisco Velasco-Barona
Cystoid macular edema

Author(s): Tryfon G Rotsos | Marilita M Moschos
Targeted therapies in the management of colorectal carcinoma: role of bevacizumab

Author(s): Ajithkumar Puthillath | Anush Patel | Marwan G Fakih
Skin rash associated with intravitreal bevacizumab in a patient with macular choroidal neovascularization

Author(s): Ioannis D Ladas | Marilita M Moschos | Thanos D Papakostas | Athanasios I Kotsolis | Ilias Georgalas | Michail Apostolopoulos
Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer

Author(s): Francesco Di Costanzo | Silvia Gasperoni | Virginia Rotella | Federica Di Costanzo
Bevacizumab (Avastin®) for the management of anterior chamber neovascularization and neovascular glaucoma

Author(s): Dimitrios Brouzas | Antonios Charakidas | Marilita Moschos | et al
Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?

Author(s): Dimitrios A Karagiannis | Ioannis D Ladas | Efstratios Parikakis | et al.
Treatment of Branch Retinal Vein Occlusion Induced Macular Edema in Treatment-naive Cases with A Single Intravitreal Triamcinolone or Bevacizumab Injection

Author(s): Chih-Hsin Chen | Yi-Hao Chen | Pei-Chang Wu | Yung-Jen Chen | Jong-Jer Lee | Ya-Chi Liu | Hsi-Kung Kuo
Central serous chorioretinopathy: a pathogenetic model

Author(s): Antonio Caccavale | Filippo Romanazzi | Manuela Imparato | et al
Tetany: Possible adverse effect of bevacizumab

Author(s): Anwikar S | Bandekar M | Patel T | Patel P | Kshirsagar N
Current approach in the treatment of hepatocellular carcinoma

Author(s): Luigi Rossi | Federica Zoratto | Anselmo Papa | Francesca Iodice | Marina Minozzi | Luigi Frati | Silverio Tomao
Capecitabine for locally advanced and metastatic colorectal cancer: A review

Author(s): Georgios V Koukourakis | Georgios Zacharias | John Tsalafoutas | Dimitrios Theodoridis | Vassilios Kouloulias
Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients

Author(s): Markus Moehler, Martin F Sprinzl, Murad Abdelfattah, Carl C Schimanski, Bernd Adami, Werner Godderz, Klaus Majer, Dimitri Flieger, Andreas Teufel, Juergen Siebler, Thomas Hoehler, Peter R Galle, Stephan Kanzler
Recombinant vascular basement-membrane-derived multifunctional peptide inhibits angiogenesis and growth of hepatocellular carcinoma

Author(s): You-Hua Wu, Jian-Guo Cao, Hong-Lin Xiang, Hong Xia, Yong Qin, A-Ji Huang, Di Xiao, Fang Xu
Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: A pilot study

Author(s): Francois Ghiringhelli, Boris Guiu, Bruno Chauffert, Sylvain Ladoire
Targeted Therapy for Biliary Tract Cancer

Author(s): Junji Furuse | Takuji Okusaka
Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucoma

Author(s): Canut MI | Alvarez A | Nadal J | Abreu R | Abreu JA | Pulido JS
Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits

Author(s): Sinapis C | Routsias JG | Sinapis A | Sinapis D | Agrogiannis G | Pantopoulou A | Theocharis SE | Baltatzis S | Patsouris E | Perrea DN
Lasting Controversy on Ranibizumab and Bevacizumab

Author(s): Lihui Zou, Huiying Lai, Qi Zhou, Fei Xiao
Bevacizumab Injection in Patients with Age-Related Macular Degeneration Associated with Poor Initial Visual Acuity

Author(s): Leila El Matri | Rym Bouraoui | Ahmed Chebil | Fedra Kort | Mejda Bouladi | Rym Limaiem | Hana Landoulsi
Bevacizumab and Weekly Docetaxel in Patients with Metastatic Castrate-Resistant Prostate Cancer Previously Exposed to Docetaxel

Author(s): Filippo Francini | Alessandra Pascucci | Edoardo Francini | Gianluca Bargagli | Raffaele Conca | Antonella Licchetta | Giandomenico Roviello | Ignazio Martellucci | Giorgio Chiriacò | Salvatora Tindara Miano | Giuseppe Marzocca | Antonio Manganelli | Roberto Ponchietti | Vinno Savelli | Roberto Petrioli
The effect of intravitreal anti-VEGF agents on peripheral wound healing in a rabbit model

Author(s): Christoforidis J | Ricketts R | Pratt C | Pierce J | Bean S | Wells M | Zhang X | La Perle K
Response evaluation of chemotherapy in metastatic colorectal cancer by contrast enhanced ultrasound

Author(s): Ramin Schirin-Sokhan | Ron Winograd | Christoph Roderburg | Jhenee Bubenzer | Nicole Cabral do Ó | Dorothee Guggenberger | Hartmut Hecker | Christian Trautwein | Jens J W Tischendorf
EFFECTIVENESS OF I AND II LINE CHEMO-TARGETED THERAPY ACCORDING TO THE SCHEME OXALIPLATIN +CAPECITABINE + BEVACIZUMAB (XELOX+BEV) IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC)

Author(s): KALDYGUL SMAGULOVA | NINO CHICHUA | ZHETKERGEN ARZYKULOV | SURIYA YESENTAYEVA | RAMIL ABDRAKHMANOV | ASSEL TUMANOVA | SHOLPAN MUKANOVA | AICHA МOLDASHEVA
Switching from Intravitreal Ranibizumab to Bevacizumab for Age-Related Macular Degeneration

Author(s): Kisaburo Yamada | Kenichi Kimoto | Hirofumi Kono | Toshiaki Kubota
Therapeutic Potential of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Agents in Orbital Lymphangioma

Author(s): Abbas Attarzadeh | Mohammad Hosein Nowroozzadeh | Mohammad Sharifi
Liposomal Formulation of Bevasizuamb for Intravitreal Administration: Increased Half-Life, Decreased Side Effects

Author(s): Bijan Malaekeh-Nikouei | Majid Abrishami | Siamak Zarei Ghanavati
Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer

Author(s): Lee Chun Park | Ho Sup Lee | Seong Hoon Shin | Seun Ja Park | Moo In Park | Sung Yong Oh | Hyuk Chan Kwon | Jin ho Baek | Young Jin Choi | Myoung Joo Kang | Yang Soo Kim
Insight into 144 patients with ocular vascular events during VEGF antagonist injections

Author(s): Mansour AM | Shahin M | Kofoed PK | Parodi MB | Shami M | Schwartz SG
Successful Treatment of Recurrent Triple-Negative Breast Cancer with Combination of Targeted Therapies

Author(s): Stanislaw R. Burzynski | Alejandro Marquis | Eva Nagy-Kubove | Tomasz Janicki
Clinical Analysis of Bevacizumab Plus FOLFIRI Regimen as Front-Line Therapy for Chinese Patients with Advanced Colorectal Cancer

Author(s): Xijian Zhou | Jun Yang | Jinying Liang | Peng Li | Yuquan Wu | Xiaoqiang Fan | Xiangyong Li
A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: The AIO KRK 0110 Trial/ML22011 Trial

Author(s): Giessen Clemens | von Weikersthal Ludwig | Hinke Axel | Stintzing Sebastian | Kullmann Frank | Vehling-Kaiser Ursula | Mayerle Julia | Bangerter Markus | Denzlinger Claudio | Sieber Markus | Teschendorf Christian | Freiberg-Richter Jens | Schulz Christoph | Modest Dominik | Moosmann Nicolas | Aubele Philipp | Heinemann Volker
Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study

Author(s): Zafar S Yousuf | Malin Jennifer | Grambow Steven | Abbott David | Schrag Deborah | Kolimaga Jane | Zullig Leah | Weeks Jane | Fouad Mona | Ayanian John | Wallace Robert | Kahn Katherine | Ganz Patricia | Catalano Paul | West Dee | Provenzale Dawn
Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study

Author(s): Velenik Vaneja | Ocvirk Janja | Music Maja | Bracko Matej | Anderluh Franc | Oblak Irena | Edhemovic Ibrahim | Brecelj Erik | Kropivnik Mateja | Omejc Mirko
Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management

Author(s): Chen Jing | Dassarath Meera | Yin Zhongyuan | Liu Hongli | Yang Kunyu | Wu Gang
Intracranial hemorrhage in patients treated with bevacizumab: Report of two cases

Author(s): Takeshi Nishimura | Makoto Furihata | Hideyuki Kubo | Masao Tani | Senichiro Agawa | Ryuhei Setoyama | Tomikatsu Toyoda
Bevacizumab Improves Quality of Life in Patients with Recurrent Glioblastoma

Author(s): Seema Nagpal | Griffith Harsh | Lawrence Recht
Subconjunctival Bevacizumab Injection in Treatment of Pterygium

Author(s): Mohammad Reza Besharati | Masoud Reza Manaviat | Azadeh Souzani
The use of bevacizumab in a multilevel retinal hemorrhage secondary to retinal macroaneurysm: a 39-month follow-up case report

Author(s): Tsakpinis D | Nasr MB | Tranos P | Krassas N | Giannopoulos T | Symeonidis C | Dimitrakos SA | Konstas AGP
Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema

Author(s): Bandello F | De Benedetto U | Knutsson KA | Battaglia Parodi M | Cascavilla ML | Iacono P
Renal cell carcinoma metastasis to the ciliary body responds to proton beam radiotherapy: a case report

Author(s): Alasil Tarek | Khazai Bahram | Loredo Lilia | Rauser Michael
Therapeutic Approaches to Target Cancer Stem Cells

Author(s): Arlhee Diaz | Kalet Leon
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials

Author(s): Cuppone Federica | Bria Emilio | Vaccaro Vanja | Puglisi Fabio | Fabi Alessandra | Sperduti Isabella | Carlini Paolo | Milella Michele | Nisticò Cecilia | Russillo Michelangelo | Papaldo Paola | Ferretti Gianluigi | Aapro Matti | Giannarelli Diana | Cognetti Francesco
Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer

Author(s): Loupakis Fotios | Ruzzo Annamaria | Salvatore Lisa | Cremolini Chiara | Masi Gianluca | Frumento Paolo | Schirripa Marta | Catalano Vincenzo | Galluccio Nadia | Canestrari Emanuele | Vincenzi Bruno | Santini Daniele | Bencardino Katia | Ricci Vincenzo | Manzoni Mariangela | Danova Marco | Tonini Giuseppe | Magnani Mauro | Falcone Alfredo | Graziano Francesco
Visual recovery in a patient with total hyphema, neovascular glaucoma, long-standing retinal detachment and no light perception vision: a case report

Author(s): Olawoye Olusola | Teng Christopher | Shabto Uri | Liebmann Jeffrey | L'Esperance Francis | Ritch Robert
Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report

Author(s): Vihinen Pia | Paija Outi | Kivisaari Atte | Koulu Leena | Aho Heikki
Long-term success of intravitreal bevacizumab for choroidal neovascularization associated with choroidal osteoma

Author(s): Kubota-Taniai M | Oshitari T | Handa M | Baba T | Yotsukura J | Yamamoto S
Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion

Author(s): Ogino K | Tsujikawa A | Murakami T | Muraoka Y | Kurashige Y | Yoshimura N
Effectiveness of maintenance treatments for nonsmall cell lung cancer

Author(s): Eadens MJ | Robinson SI | Price KA
Bevacizumab Related Hypertension and Reversible Posterior Leukoencephalopathy Syndrome in Gynecologic Malignancies: A case Control Study

Author(s): Sarah N. Cross | Elena S. Ratner | Dan A. Silasi | Alessandro D. Santin | Masoud Azodi | Thomas J. Rutherford | Peter E. Schwartz
Predictive Biomarkers for Bevacizumab in Anti-tumor Therapy

Author(s): Qingqing PAN | Mengzhao WANG
Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion

Author(s): Udaondo P | Garcia-Delpech S | Salom D | Garcia-Pous M | Diaz-Llopis M.
Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma

Author(s): Sedghipour MR | Mostafaei A | Taghavi Y

Tango Rapperswil
Tango Rapperswil

     Affiliate Program